Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trialMagdy Selim, Heena Olalde, Steven M. Greenberg et al.|The Lancet Neurology|2019Cited by 249
Applying a Phase II Futility Study Design to Therapeutic Stroke TrialsYuko Y. Palesch, Robert F. Woolson|Stroke|2005Cited by 59
An Overview of the Adaptive Designs Accelerating Promising Trials Into Treatments (ADAPT-IT) ProjectWilliam J. Meurer, William G. Barsan, Roger J. Lewis et al.|Annals of Emergency Medicine|2012Cited by 49